Skip to main content
Top
Published in: Basic Research in Cardiology 2/2011

Open Access 01-03-2011 | Original Contribution

Exercise-induced modulation of cardiac lipid content in healthy lean young men

Authors: L. Bilet, T. van de Weijer, M. K. C. Hesselink, J. F. C. Glatz, H. J. Lamb, J. Wildberger, M. E. Kooi, P. Schrauwen, V. B. Schrauwen-Hinderling

Published in: Basic Research in Cardiology | Issue 2/2011

Login to get access

Abstract

Cardiac lipid accumulation is associated with decreased cardiac function and energy status (PCr/ATP). It has been suggested that elevated plasma fatty acid (FA) concentrations are responsible for the cardiac lipid accumulation. Therefore, the aim of the present study was to investigate if elevating plasma FA concentrations by exercise results in an increased cardiac lipid content, and if this influences cardiac function and energy status. Eleven male subjects (age 25.4 ± 1.1 years, BMI 23.6 ± 0.8 kg/m2) performed a 2-h cycling protocol, once while staying fasted and once while ingesting glucose, to create a state of high versus low plasma FA concentrations, respectively. Cardiac lipid content was measured by proton magnetic resonance spectroscopy (1H-MRS) at baseline, directly after exercise and again 4 h post-exercise, together with systolic function (by multi-slice cine-MRI) and cardiac energy status (by 31P-MRS). Plasma FA concentrations were increased threefold during exercise and ninefold during recovery in the fasted state compared with the glucose-fed state (p < 0.01). Cardiac lipid content was elevated at the end of the fasted test day (from 0.26 ± 0.04 to 0.44 ± 0.04%, p = 0.003), while it did not change with glucose supplementation (from 0.32 ± 0.03 to 0.26 ± 0.05%, p = 0.272). Furthermore, PCr/ATP was decreased by 32% in the high plasma FA state compared with the low FA state (n = 6, p = 0.014). However, in the high FA state, the ejection fraction 4 h post-exercise was higher compared with the low FA state (63 ± 2 vs. 59 ± 2%, p = 0.018). Elevated plasma FA concentrations, induced by exercise in the fasted state, lead to increased cardiac lipid content, but do not acutely hamper systolic function. Although the lower cardiac energy status is in line with a lipotoxic action of cardiac lipid content, a causal relationship cannot be proven.
Literature
1.
go back to reference Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10(11):1245–1250. doi:10.1038/nm1116 PubMedCrossRef Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10(11):1245–1250. doi:10.​1038/​nm1116 PubMedCrossRef
2.
go back to reference Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE (2005) Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 96(2):225–233. doi:10.1161/01.RES.0000154079.20681.B9 PubMedCrossRef Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE (2005) Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 96(2):225–233. doi:10.​1161/​01.​RES.​0000154079.​20681.​B9 PubMedCrossRef
3.
4.
go back to reference Hansch A, Rzanny R, Heyne JP, Leder U, Reichenbach JR, Kaiser WA (2005) Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging. Eur Radiol 15(2):319–323. doi:10.1007/s00330-004-2504-0 PubMedCrossRef Hansch A, Rzanny R, Heyne JP, Leder U, Reichenbach JR, Kaiser WA (2005) Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging. Eur Radiol 15(2):319–323. doi:10.​1007/​s00330-004-2504-0 PubMedCrossRef
5.
go back to reference Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P (2006) Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91(11):4689–4695. doi:10.1210/jc.2006-0584 PubMedCrossRef Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P (2006) Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91(11):4689–4695. doi:10.​1210/​jc.​2006-0584 PubMedCrossRef
6.
go back to reference Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313PubMedCrossRef Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313PubMedCrossRef
8.
9.
go back to reference Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, de Roos A (1996) Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed 9(5):217–227PubMedCrossRef Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, de Roos A (1996) Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed 9(5):217–227PubMedCrossRef
11.
go back to reference Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27(1):96–106. doi:10.1093/eurheartj/ehi506 PubMedCrossRef Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27(1):96–106. doi:10.​1093/​eurheartj/​ehi506 PubMedCrossRef
13.
go back to reference Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M (2003) Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42(9):1587–1593. doi:10.1016/j.jacc.2003.05.005 PubMedCrossRef Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M (2003) Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42(9):1587–1593. doi:10.​1016/​j.​jacc.​2003.​05.​005 PubMedCrossRef
14.
go back to reference Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T, Morikawa S, Inubushi T, Horie M (2010) Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Card Fail 16(10):812–822. doi:10.1016/j.cardfail.2010.05.006 PubMedCrossRef Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T, Morikawa S, Inubushi T, Horie M (2010) Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Card Fail 16(10):812–822. doi:10.​1016/​j.​cardfail.​2010.​05.​006 PubMedCrossRef
15.
go back to reference Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for the MRUI quantitation package. Magma 12(2–3):141–152PubMedCrossRef Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for the MRUI quantitation package. Magma 12(2–3):141–152PubMedCrossRef
16.
17.
go back to reference Nielsen LB, Bartels ED, Bollano E (2002) Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 277(30):27014–27020. doi:10.1074/jbc.M203458200 PubMedCrossRef Nielsen LB, Bartels ED, Bollano E (2002) Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 277(30):27014–27020. doi:10.​1074/​jbc.​M203458200 PubMedCrossRef
18.
go back to reference Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS (2005) Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289(5):E935–E939. doi:10.1152/ajpendo.00095.2005 PubMedCrossRef Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS (2005) Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289(5):E935–E939. doi:10.​1152/​ajpendo.​00095.​2005 PubMedCrossRef
19.
go back to reference Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ (2010) Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 56(3):225–233. doi:10.1016/j.jacc.2010.02.049 PubMedCrossRef Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ (2010) Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 56(3):225–233. doi:10.​1016/​j.​jacc.​2010.​02.​049 PubMedCrossRef
22.
go back to reference Schrauwen P, Hesselink MK, Vaartjes I, Kornips E, Saris WH, Giacobino JP, Russell A (2002) Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect. Am J Physiol Endocrinol Metab 282(1):E11–E17PubMed Schrauwen P, Hesselink MK, Vaartjes I, Kornips E, Saris WH, Giacobino JP, Russell A (2002) Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect. Am J Physiol Endocrinol Metab 282(1):E11–E17PubMed
23.
go back to reference Schrauwen-Hinderling VB, Hesselink MK, Meex R, van der Made S, Schar M, Lamb H, Wildberger JE, Glatz J, Snoep G, Kooi ME, Schrauwen P (2010) Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. J Clin Endocrinol Metab 95(4):1932–1938. doi:10.1210/jc.2009-2076 PubMedCrossRef Schrauwen-Hinderling VB, Hesselink MK, Meex R, van der Made S, Schar M, Lamb H, Wildberger JE, Glatz J, Snoep G, Kooi ME, Schrauwen P (2010) Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. J Clin Endocrinol Metab 95(4):1932–1938. doi:10.​1210/​jc.​2009-2076 PubMedCrossRef
24.
go back to reference Schrauwen-Hinderling VB, van Loon LJ, Koopman R, Nicolay K, Saris WH, Kooi ME (2003) Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle. J Appl Physiol 95(6):2328–2332. doi:10.1152/japplphysiol.00304.2003 PubMed Schrauwen-Hinderling VB, van Loon LJ, Koopman R, Nicolay K, Saris WH, Kooi ME (2003) Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle. J Appl Physiol 95(6):2328–2332. doi:10.​1152/​japplphysiol.​00304.​2003 PubMed
25.
go back to reference Schwarzer M, Britton SL, Koch LG, Wisloff U, Doenst T (2010) Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity. Basic Res Cardiol 105(3):357–364. doi:10.1007/s00395-010-0087-2 PubMedCrossRef Schwarzer M, Britton SL, Koch LG, Wisloff U, Doenst T (2010) Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity. Basic Res Cardiol 105(3):357–364. doi:10.​1007/​s00395-010-0087-2 PubMedCrossRef
26.
go back to reference Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H (2004) Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18(14):1692–1700. doi:10.1096/fj.04-2263com PubMedCrossRef Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H (2004) Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18(14):1692–1700. doi:10.​1096/​fj.​04-2263com PubMedCrossRef
27.
go back to reference Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS (1999) Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100(20):2113–2118PubMed Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS (1999) Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100(20):2113–2118PubMed
28.
go back to reference Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239–280PubMed Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239–280PubMed
29.
go back to reference Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276(5 Pt 1):E977–E989PubMed Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276(5 Pt 1):E977–E989PubMed
30.
go back to reference Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D’Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG (2003) Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49(3):417–423. doi:10.1002/mrm.10372 PubMedCrossRef Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D’Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG (2003) Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49(3):417–423. doi:10.​1002/​mrm.​10372 PubMedCrossRef
32.
go back to reference van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ (2007) Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245(1):251–257. doi:10.1148/radiol.2451061904 PubMedCrossRef van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ (2007) Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245(1):251–257. doi:10.​1148/​radiol.​2451061904 PubMedCrossRef
33.
go back to reference van der Meer RW, Hammer S, Smit JW, Frolich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ (2007) Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56(12):2849–2853. doi:10.2337/db07-0768 PubMedCrossRef van der Meer RW, Hammer S, Smit JW, Frolich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ (2007) Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56(12):2849–2853. doi:10.​2337/​db07-0768 PubMedCrossRef
35.
go back to reference Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ (2003) Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111(3):419–426. doi:10.1172/JCI16751 PubMed Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ (2003) Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111(3):419–426. doi:10.​1172/​JCI16751 PubMed
36.
go back to reference Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97(4):1784–1789PubMedCrossRef Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97(4):1784–1789PubMedCrossRef
Metadata
Title
Exercise-induced modulation of cardiac lipid content in healthy lean young men
Authors
L. Bilet
T. van de Weijer
M. K. C. Hesselink
J. F. C. Glatz
H. J. Lamb
J. Wildberger
M. E. Kooi
P. Schrauwen
V. B. Schrauwen-Hinderling
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Basic Research in Cardiology / Issue 2/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-010-0144-x

Other articles of this Issue 2/2011

Basic Research in Cardiology 2/2011 Go to the issue